300149 睿智医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额120,235168,207150,992262,460378,220
投资活动产生之现金流量净额(54,486)(67,668)(12,820)1,007,779(210,887)
筹资活动产生之现金流量净额(65,053)(86,436)(388,341)(860,110)(259,361)
汇率变动对现金及现金等价物的影响(1,755)7,1176,97522,301(813)
现金及现金等价物净增加/(减少)(1,058)21,219(243,194)432,431(92,841)
期初现金及现金等价物余额363,449342,229585,424152,993245,834
期末现金及现金等价物余额362,390363,449342,229585,424152,993